公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
公司地址 300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712
電話號碼 +1 201 329-7300
傳真號碼 +1 201 329-7399
公司網頁 https://www.pahc.com
員工數量 2475
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Lisa A. Escudero Senior Vice President, Human Resources -- 19/09/2025
Mr. Glenn C. David Chief Financial Officer 美元 672.77K 19/09/2025
Mr. Jonathan Bendheim Director and Senior Vice President, Global Technologies and Talent -- 19/09/2025
Mr. Daniel M. Bendheim Director and Executive Vice President, Corporate Strategy 美元 575.00K 18/12/2025
Mr. Larry L. Miller Chief Operating Officer 美元 710.85K 19/09/2025
Mr. Anthony Andolino Vice President, Finance and Treasurer -- 19/09/2025
Ms. Judith Weinstein Senior Vice President, General Counsel and Corporate Secretary 美元 500.00K 19/09/2025
Mr. Jack Clifford Bendheim Chairman of the Board, President and Chief Executive Officer 美元 2.44M 18/12/2025
 
董事會成員
董事會 職務 更新日期
Ms. Joyce J. Lee Independent Director 19/09/2025
Ms. Carol A. Wrenn Independent Director 19/09/2025
Mr. Jonathan Bendheim Director and Senior Vice President, Global Technologies and Talent 19/09/2025
Mr. E. Thomas Corcoran Independent Director 19/09/2025
Mr. Daniel M. Bendheim Director and Executive Vice President, Corporate Strategy 18/12/2025
Mr. Alejandro Bernal, D.V.M.,M.B.A.,M.S. Independent Director 19/09/2025
Ms. Mary Louise Malanoski Independent Director 19/09/2025
Mr. Sam Gejdenson Independent Director 19/09/2025
Mr. Jack Clifford Bendheim Chairman of the Board, President and Chief Executive Officer 18/12/2025
 
所屬ETF (更新日期: 07/03/2026 03:49)
代號 名稱 佔比% 持有日期
BSMCBrandes U.S. Small-Mid Cap Value ETF<0.000001%09/10/2025
BUYOKraneShares Man Buyout Beta Index ETF<0.000001%03/11/2025
DFATDimensional US Targeted Value ETF<0.000001%25/07/2025
DWASInvesco Dorsey Wright SmallCap Momt ETF<0.000001%02/01/2026
EWSCInvesco S&P SmallCap 600® Equal Wt ETF<0.000001%20/03/2023
FDLSInspire Fidelis Multi Factor ETF<0.000001%19/12/2025
FFTYInnovator IBD® 50 ETF<0.000001%24/11/2025
IJSiShares S&P Small-Cap 600 Value ETF<0.000001%28/02/2026
IWNiShares Russell 2000 Value ETF<0.000001%28/02/2026
LITLSimplify Piper Sandler USSm-CpPLUSIncETF<0.000001%31/12/2025
PTHInvesco Dorsey Wright Healthcare MomtETF<0.000001%02/01/2026
QQQSInvesco NASDAQ Future Gen 200 ETF<0.000001%23/12/2025
SMMDiShares Russell 2500 ETF<0.000001%27/02/2026
VFMFVanguard US Multifactor ETF<0.000001%30/09/2025
VTWVVanguard Russell 2000 Value ETF<0.000001%30/06/2025
  1    2    3    4   5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.